Financhill
Back

Vertex Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53

VRTX
Vertex Pharmaceuticals, Inc.

Last Price:
$460.28
Seasonality Move:
7.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Vertex Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Vertex Pharmaceuticals, Inc. has on average historically risen by 28.9% based on the past 34 years of stock performance.
  • Vertex Pharmaceuticals, Inc. has risen higher in 22 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%
  • Is Vertex Pharmaceuticals, Inc. Stock Undervalued?
    The current Vertex Pharmaceuticals, Inc. [VRTX] share price is $460.31. The Score for VRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Vertex Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Vertex Pharmaceuticals, Inc. has on average historically risen by 28.9% based on the past 34 years of stock performance.

Vertex Pharmaceuticals, Inc. Stock Rating

Buy
53
Vertex Pharmaceuticals, Inc. (VRTX) is a Buy

Is Vertex Pharmaceuticals, Inc. overpriced?

  • Vertex Pharmaceuticals, Inc. has risen higher in 22 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%

Vertex Pharmaceuticals, Inc. Stock Price History

Is VRTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com

52-Week Data

52-Week High:
519.68
52-Week Low:
362.50

Prediction Charts

Market Cap:
116.8B
Price in USD:
460.31
Volume:
919.6K
Beta:
0.93

Technical Analysis

SMA50:
431.21
SMA100:
413.27
SMA200:
440.98
52-Wk Change:
15.87%

Stock Predictions

  • Is Vertex Pharmaceuticals, Inc. stock public?
    Yes, Vertex Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Vertex Pharmaceuticals, Inc. stock quote today?
    The Vertex Pharmaceuticals, Inc. stock price is 460.31 USD today.
  • How to buy Vertex Pharmaceuticals, Inc. stock online?
    You can buy Vertex Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 440.31 463.13 463.85 439.35
Dec-4 462.00 457.36 463.70 453.54
Dec-5 457.78 455.48 462.00 454.46
Dec-8 455.65 442.04 457.17 439.80
Dec-9 442.55 437.01 448.28 436.49
Dec-10 438.81 444.64 446.28 433.81
Dec-11 445.65 445.93 448.33 442.07
Dec-12 444.81 452.04 456.00 444.81
Dec-15 454.28 455.71 456.46 449.48
Dec-16 455.71 454.96 459.05 452.83
Dec-17 453.83 449.52 456.05 447.31
Dec-18 449.74 447.38 452.63 445.41
Dec-19 446.86 456.20 460.40 445.51
Dec-22 454.34 460.31 460.94 453.03

Vertex Pharmaceuticals, Inc. Earnings

Vertex Pharmaceuticals, Inc. Earnings Report: Per Share Vertex Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vertex Pharmaceuticals, Inc. Forecast Revenue Growth

Vertex Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.96 per share, and an increase next year of $1.79 per share.

* Vertex Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.